Cel-Sci is publicly upbeat about a cancer drug. Privately it tried to sell stock

Cel-Sci is publicly upbeat about a cancer drug. Privately it tried to sell stock

STAT Plus: Cel-Sci is publicly upbeat about its cancer drug. Privately it’s trying to sell stock

By ADAM FEUERSTEIN

Trying to sell stock now on the down-low reveals a harsher truth about Cel-Sci and is an ominous tell for the fate of its immunotherapy.

READ MORE